Cite

    Oliver Pfaar et al.. “Clinically relevant outcome measures for new pharmacotherapy, allergen avoidance and immunotherapy trials in allergic rhinoconjunctivitis.” Current opinion in allergy and clinical immunology, vol. 15, no. 3, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100025901211.0x00002a